Skip to main content
Equibles
ACH logo

ACH · Accendra Health Inc/Va/

Track ACH — free

Use ACH with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.17 +0.02 (+1.74%) At close · Sep 2
Russell 2000 member Rebalance outlook locked
Market Cap
$91.90M
Shares
76.90M

ACH metrics

68 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.17
Market cap
$91.90M

Price action

19 metrics
Price change (1W)
-0.9%
Price change (30D)
-66.3%
Price change (3M)
-59.4%
Price change (6M)
-52.1%
Price change (YTD)
-58.9%
Price change (1Y)
-76.5%
Trailing year
Price change (5Y)
-97.0%
52-week high
$5.62
52-week low
$0.95
Change from 52-week high
-79.5%
Change from 52-week low
+21.1%
Annualized volatility
97.8%
Beta
0.9
RSI (14D)
28.5
Price vs SMA 50
-55.5%
Price vs SMA 200
-57.0%
Avg volume (3M)
1.14M
Relative volume
0.9
Average dollar volume
$2.38M

Company

3 metrics
Sector
Healthcare
Industry
Medical Distribution
Shares outstanding
76.90M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.0×
reciprocal yield 2,856.6%
P / book
—
FCF yield
-385.4%
TTM · current market cap
Buyback yield
9.4%
P / FCF
—
P / operating cash flow
—
Earnings yield
-326.0%

Historical valuation

8 metrics
P / E historical average (3Y)
24.2×
reciprocal yield 4.1%
P / E historical average (5Y)
24.2×
reciprocal yield 4.1%
EV / revenue historical average (3Y)
0.3×
reciprocal yield 286.7%
EV / revenue historical average (5Y)
0.3×
reciprocal yield 286.7%
EV / EBIT historical average (3Y)
20.1×
reciprocal yield 5.0%
EV / EBIT historical average (5Y)
20.1×
reciprocal yield 5.0%
EV / EBITDA historical average (3Y)
10.3×
reciprocal yield 9.7%
EV / EBITDA historical average (5Y)
10.3×
reciprocal yield 9.7%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
2021-12-14

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-10

Profitability

9 metrics
Gross margin
—
Operating margin
1.1%
Trailing 12 months
Net margin
-11.4%
Gross profit (TTM)
$2.21B
Operating profit (TTM)
$29.35M
Net income (TTM)
−$302.14M
Trailing 12 months
Diluted EPS (TTM)
$-3.93
FCF margin
-13.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-7.16

Growth

11 metrics
Revenue growth YoY
-10.1%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.65B
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-0.3%
Year over year · fewer shares
Revenue CAGR (3Y)
-34.8%
Revenue CAGR (5Y)
-20.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-14.3%
Debt / equity
—
Current ratio
0.4
EBITDA (TTM)
$285.43M
Free cash flow (TTM)
−$357.19M
Quick ratio
0.3
Interest coverage
0.2
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$7.65M
Total assets
$2.11B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$180.42M
Capital expenditures (TTM)
$176.77M
R&D (TTM)
—
SG&A (TTM)
$1.04B
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
141
13F filer change QoQ
-2
Institutional ownership
82.9%

Short interest

3 metrics
Short interest
8.4%
Latest settlement · 2.6 days to cover
Days to cover
2.6d
Short-squeeze score
66 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 75252 CUSIP 690732102 13F (30d) 119 filings 116 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)